Formica V, Roselli M. Targeted therapy in first line treatment of RAS wild type colorectal cancer. World J Gastroenterol 2015; 21(10): 2871-2874 [PMID: 25780283 DOI: 10.3748/wjg.v21.i10.2871]
Corresponding Author of This Article
Vincenzo Formica, MD, PhD, Medical Oncology Unit, Department of Internal Medicine, “Tor Vergata” University Hospital, Viale Oxford 81, 00133 Rome, Italy. vincenzo.formica@uniroma2.it
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/